Induction of immunologic memory in Gambian children by vaccination in infancy with a group A plus group C meningococcal polysaccharide-protein conjugate vaccine
- PMID: 8985221
- DOI: 10.1093/infdis/175.1.200
Induction of immunologic memory in Gambian children by vaccination in infancy with a group A plus group C meningococcal polysaccharide-protein conjugate vaccine
Abstract
Two hundred twenty-one Gambian children vaccinated previously with one, two, or three doses of a meningococcal conjugate vaccine or two doses of polysaccharide vaccine before the age of 6 months were revaccinated at the age of 18-24 months with either meningococcal polysaccharide, conjugate, or inactivated polio vaccines. Children who had previously received one, two, or three doses of conjugate vaccine had significantly (P < .001) higher anti-group C meningococcal antibody levels following revaccination than did children vaccinated with a polysaccharide vaccine for the first time. Children vaccinated previously with two doses of polysaccharide vaccine had a lower group C antibody response than did control children. Group A antibody responses following revaccination of children who had previously received polysaccharide or conjugate vaccine were not significantly higher than those in control children. Thus, immunologic memory was probably induced by the group C but not by the group A component of the conjugate vaccine.
Similar articles
-
Induction of immunologic memory by conjugated vs plain meningococcal C polysaccharide vaccine in toddlers: a randomized controlled trial.JAMA. 1998 Nov 18;280(19):1685-9. doi: 10.1001/jama.280.19.1685. JAMA. 1998. PMID: 9832000 Clinical Trial.
-
Immunologic memory 5 years after meningococcal A/C conjugate vaccination in infancy.J Infect Dis. 2001 Jan 1;183(1):97-104. doi: 10.1086/317667. Epub 2000 Nov 15. J Infect Dis. 2001. PMID: 11087205 Clinical Trial.
-
Safety, immunogenicity, and induction of immunologic memory by a serogroup C meningococcal conjugate vaccine in infants: A randomized controlled trial.JAMA. 2000 Jun 7;283(21):2795-801. doi: 10.1001/jama.283.21.2795. JAMA. 2000. PMID: 10838647 Clinical Trial.
-
Long-term protection after immunization with protein-polysaccharide conjugate vaccines in infancy.Expert Rev Vaccines. 2011 May;10(5):673-84. doi: 10.1586/erv.11.14. Expert Rev Vaccines. 2011. PMID: 21604987 Review.
-
MenACWY-TT vaccine for active immunization against invasive meningococcal disease.Expert Rev Vaccines. 2012 May;11(5):523-37. doi: 10.1586/erv.12.32. Expert Rev Vaccines. 2012. PMID: 22827239 Review.
Cited by
-
Priming for immunologic memory in adults by meningococcal group C conjugate vaccination.Clin Vaccine Immunol. 2006 Jun;13(6):605-10. doi: 10.1128/CVI.00123-06. Clin Vaccine Immunol. 2006. PMID: 16760316 Free PMC article. Clinical Trial.
-
Dramatic decline of serogroup C meningococcal disease incidence in Catalonia (Spain) 24 months after a mass vaccination programme of children and young people.J Epidemiol Community Health. 2001 Apr;55(4):283-7. doi: 10.1136/jech.55.4.283. J Epidemiol Community Health. 2001. PMID: 11238585 Free PMC article.
-
Concomitant administration of Mycobacterium bovis BCG with the meningococcal C conjugate vaccine to neonatal mice enhances antibody response and protective efficacy.Clin Vaccine Immunol. 2011 Nov;18(11):1936-42. doi: 10.1128/CVI.05247-11. Epub 2011 Sep 7. Clin Vaccine Immunol. 2011. PMID: 21900528 Free PMC article.
-
Conjugate vaccines.Clin Exp Immunol. 2000 Jan;119(1):1-3. doi: 10.1046/j.1365-2249.2000.01109.x. Clin Exp Immunol. 2000. PMID: 10671089 Free PMC article. Review. No abstract available.
-
Preventing Infections by Encapsulated Bacteria Through Vaccine Prophylaxis in Inflammatory Bowel Disease.Front Immunol. 2020 Mar 23;11:485. doi: 10.3389/fimmu.2020.00485. eCollection 2020. Front Immunol. 2020. PMID: 32269571 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources